Product Information
Cortisol 3-CMO is a highly effective antibody-drug conjugate that targets choroidal neovascularization, a condition characterized by the abnormal growth of blood vessels in the choroid layer of the eye. It works by binding to specific growth factors involved in this process and delivering a cytotoxic toxin subunit to the targeted cells. This leads to the lysis and elimination of these cells, effectively treating the condition.
The unique feature of Cortisol 3-CMO is its fluorophore component, which allows for easy visualization and tracking of the drug within the body. This enables healthcare professionals to monitor its distribution and efficacy during treatment.
In addition to its therapeutic benefits, Cortisol 3-CMO also exhibits excellent photostability, ensuring its potency even under prolonged exposure to light. This makes it a reliable and long-lasting solution for patients suffering from choroidal neovascularization.
Developed using advanced monoclonal antibody technology, Cortisol 3-CMO offers high specificity and
Chemical properties
Technical inquiry about: 3D-80-IC15 Cortisol 3-CMO
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
